Overview
TRLV market data
Price History
TRLV price chart · 1M
- O
- 11.42
- H
- 11.46
- L
- 11.06
- C
- 11.10
- Vol
- 32,440.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $11.42
- Previous Close
- $11.42
- Day High
- $11.46
- Day Low
- $11.06
- 52 Week High
- $12.05
- 52 Week Low
- $7.88
- 7 Day Return
- +8.08%
- 30 Day Return
- +33.25%
- 90 Day Return
- -3.48%
- 1 Year Return
- -3.48%
- Daily Notional Volume
- $360.1K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.61 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.36 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -6.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $7.82 – $12.30 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.9B · P/S 1.59.
Company News
Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price TargetBenzinga · Aug 7, 2026, 6:03 PM
Trulieve Cannabis Q2 Adj. EPS $0.11 Beats $0.06 Estimate, Sales $271.000M Beat $268.494M EstimateBenzinga · Aug 7, 2026, 1:04 PM
8-K filing — Trulieve Cannabis Corp. (TRLV)SEC EDGAR · Aug 7, 2026, 10:17 AM
Cantor Fitzgerald Initiates Coverage On Trulieve Cannabis with Overweight Rating, Announces Price Target of $15Benzinga · Jul 20, 2026, 11:25 AM
Trulieve Cannabis CEO To Terminate 10b5-1 Share Sale Plan After Completing First Tranche Of 2.5M Share DispositionBenzinga · Jun 26, 2026, 8:35 PM
Jim Cramer Calls CAVA 'Tasty, Clean, Fun,' Says Make This Biotech 'Your Speculation'Benzinga · Jun 17, 2026, 11:55 AM
Trulieve Makes History As First US Cannabis Stock On NYSEBenzinga · Jun 10, 2026, 9:30 PM